Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study - Noordman, B J; Spaander, M CW; Valkema, R (Lancet Oncol, 2018)
et al.